Pioneering Drug Development and Computational Biology

Our portfolio is consisted on exciting startups of Biotech, Computational Biology and Digital Pharma

About VLX Ventures

At VLX Ventures, we transform visionary ideas into impactful realities. We identify cutting-edge technologies and following an intensive R&D and business validation we establish startups to grow them. This process includes recruiting strong teams, invest in and take a role part in accelerate their growth.Our primary focus is on biopharma therapeutic ventures developing drugs for challenging diseases.

 We also focus on digital pharma ventures that combine deep biology with computational biology to enable efficient, life-saving precision medicine and diagnostics.

We have established companies that push the boundaries of technology and business with the clear goal of saving lives and dramatically improving the quality of life for millions. Our diverse portfolio includes companies at all stages, from early pre-clinical to Phase 3 advanced clinical studies.

Portfolio

computational biology

Multiomics, cancer

Autism

IVF, fertility

Immunotherapy cancer

pharma

Anti infective drugs

Targeted Neutrophilic therapy

Cell therapy- Cancer

Ophthalmology

Ophthalmology

Meet our team

תמונה אורי
CEO & Board Member

Ori Choshen

eli-sorzon-a
CFO

Eli Sorzon

lior-carmon-3-121x121
CIO

Dr. Lior Carmon

moran-121x121
CBDO

Moran Ben David

תמונה אורי
CEO & Board Member

Ori Choshen

ענת-סגל-121x121
Board Member

Anat Tsour Segal

erez-meltzer-121x121
Board Member

Erez Meltzer

אלעד1-121x121
Board Member

Elad Duschak

Gabi-121x121
Advisory Board

Prof. Gabi Barabash MD, MPH

רונית3-121x121
Advisory Board

Prof. Ronit Satchi-Fainaro, Ph.D.

Skip to content